Submitted by Anonymous (not verified) on 21 October 2025 - 15:12
Opinion/decision on a Paediatric investigation plan (PIP): Zerbaxa, ceftolozane,tazobactam, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Infections and infestations, PIP number: P/0381/2024
Source: